(Reuters) – The Apple Watch was able to detect irregular heart pulse rates that could signal the need for further monitoring for a serious heart rhythm problem, according to data from a large study funded by Apple Inc (AAPL.O), demonstrating a potential future role for wearable consumer technology in healthcare.
Researchers hope the technology can assist in early detection of atrial fibrillation, the most common form of irregular heart beat. Patients with untreated AF are five times more likely to have a stroke.
The US Food and Drug Administration (#FDA) has cautiously moved to embrace Digital Therapeutics, mobile trial platforms and expanded use of real world evidence (#RWE) mining for clinical development: this progress will continue to drive sponsor investment.
Substantively, the agency has issued landmark approvals of digital products including Pear’s reSET, Proteus/Otsuka’s Abilify MyCite, and earlier WellDoc’s BlueStar.
The list of companies with digital products in development that will be seeking approval is growing.
This non-invasive brain training solution uses an electroencephalogram (EEG) measurement device + Personalized brain exercises on an app. URGONight, the first non-invasive daytime brain training solution for a better sleep, is named as a CES 2019 Innovation Award Nominee in the Wearable Technology category.
How Does the Neurofeedback Method Work?
Developed by neuroscientists and sleep experts, URGONight uses the same technology previously only available to clinics and sleep researchers. Now, EEG-feedback therapy for sleep is available in the comfort of your own home.